Xspray Pharma Partners with EVERSANA for the U.S. Launch and Commercialization of its Lead Product Dasynoc

Recent Press Releases

• EVERSANA Named a Great Place to Work for Six Consecutive Years; Now Certified Across Nine Countries
• EVERSANA Transforms Pharmacovigilance & Drug Safety Industry with Oracle Collaboration, New Global Patient Support Model
• EVERSANA Expands Safety Case Management Capabilities with Oracle
• EVERSANA President Greg Skalicky Named to Prestigious 2024 PharmaVoice 100 List
• EVERSANA Expands Global Commercialisation Operations With Berlin, Germany Office